Customer Portal Help Desk: 1-800-834-8618
LIMS IQ Comparison DOC ORCHARD-HARVEST-ALTERNATIVE
REV 2026-09

Orchard Harvest Alternatives After the Clinisys Acquisition

Clinisys acquired Orchard Software in July 2025 and Harvest now carries the Clinisys name. A neutral guide to what small labs should check after a vendor acquisition, when to stay, and what a fixed-price cloud LIS such as LIMS IQ Lite offers as an alternative.

Request a demo Read the guide

Quick answer: Orchard Harvest is now Clinisys Harvest. Clinisys, a Roper Technologies company, announced its acquisition of Orchard Software from Francisco Partners on July 29, 2025, and states that Orchard products will continue to be available and supported under the Clinisys name. For a physician office or small clinical lab, the acquisition is a reason to ask questions about roadmap, support and contract terms, not by itself a reason to switch. Labs that do want a fixed-price cloud alternative can compare LIMS IQ Lite at $999 per month with no setup fee, alongside other vendors named below.

Competitor details are taken from public sources as of September 2026 and may change; verify with each vendor.

What happened: the Clinisys acquisition of Orchard Software

The facts, from Clinisys’s own announcement and site as of September 2026:

  • On July 29, 2025, Clinisys announced it had acquired Orchard Software from Francisco Partners, the investment firm that had owned Orchard since 2019. Clinisys is part of Roper Technologies. Financial terms were not disclosed. [1]
  • Clinisys described Orchard as a “proven solution in the physician office, reference, and veterinary laboratory space” serving “more than 2,000 laboratories across the United States in physician groups, hospitals, reference labs, student health centers, veterinary clinics, and public health organizations.” [1]
  • Clinisys’s Orchard page states that “Orchard Software is now Clinisys” and that “Orchard Software solutions, which are now branded with the Clinisys name, will continue to be available and supported.” The products listed are Clinisys Orchard Point-of-Care, Clinisys Orchard Enterprise and Clinisys Orchard Harvest. [2]
  • Harvest 14 and Harvest 15 received ONC health IT certification on May 18, 2026 under the Clinisys developer name, which indicates continued release activity. The same listing notes an annual support contract fee and a per-interface fee for certified interfaces added after the original installation. [2]
  • The Clinisys Harvest product page includes the line “To learn more about converting from Clinisys Harvest to Clinisys Orchard, please contact our team.” [3]

That is what is public. Clinisys has not published a Harvest end-of-life date, a roadmap document or pricing, and this page does not speculate about any of them.

Why an acquisition is a prompt to re-evaluate, not a verdict

Vendor acquisitions in laboratory informatics are common and often benign: the acquirer adds resources, the product continues, and customers notice little. They can also change priorities over a period of years as the acquirer rationalizes an expanded portfolio. Neither outcome is knowable from outside, which is why the sensible response is to ask, in writing, and to decide on the answers.

The questions any lab should put to any LIS vendor after an acquisition:

Roadmap. Which products in the combined portfolio receive new development, and what is the published plan for the product the lab runs? Are there release notes since the acquisition? For Harvest, the May 2026 ONC certification of versions 14 and 15 is evidence of continued releases [2]; ask what those versions contain and what comes next.

Conversion expectations. If the vendor invites conversion to another product in its portfolio, as the Clinisys Harvest page does [3], ask whether conversion is optional, what it costs, who performs the data migration and interface rebuild, and what the timeline is. A conversion to a sibling product is itself an LIS implementation and should be evaluated against alternatives on the same footing.

Support continuity. Which team supports the lab now, in which hours, through which channel, and with what escalation path? Have named contacts changed?

Contract terms. Read the assignment clause (did the contract transfer to the new entity?), the renewal term and notice period, any price-change provisions, and the data export clause: which data, in which format, at what cost, within what time after termination. Export terms decide whether the lab can leave at all.

Interface ownership. Who owns the analyzer and EHR interfaces the lab runs, and what does it cost to add one? The ONC listing for Harvest notes a per-interface fee for interfaces not implemented at original installation [2]; confirm the current figure.

If the answers are satisfactory, staying is a perfectly good decision.

What Clinisys Harvest is publicly positioned for

According to the Clinisys product page as of September 2026, Harvest is “a comprehensive LIS designed with lab expertise” that “maximizes process automation and decision-support technology,” offers “SaaS deployment,” provides “rules-based decision-support technology,” and includes a Webstation through which “providers can place orders and retrieve patient results online.” Clinisys states its “expert interface team has built thousands of custom connections with analyzers, EHRs, billing systems, and more.” [3] The acquisition announcement places Orchard’s strength in physician office, reference and veterinary laboratories. [1] Orchard Enterprise, now Clinisys Orchard, is positioned separately for “high-volume, complex workflows.” [4]

Pricing is on request per the Clinisys site (checked September 2026); no list price is published. [3]

When staying on Harvest is the right call

Be honest about switching cost. A lab should stay when:

  • The lab’s analyzers and EHR are interfaced and stable, and rebuilding those interfaces elsewhere would cost more than any subscription saving.
  • The lab uses capabilities that are specific strengths of the Orchard portfolio — point-of-care device integration, a veterinary workflow, or an established outreach program.
  • Renewal pricing and support terms are acceptable and confirmed in writing.
  • Clinisys has answered the roadmap and conversion questions above to the lab’s satisfaction.

Switching an LIS is a project with validation, training and parallel-run cost. It should follow a clear reason: an unacceptable renewal quote, a forced conversion the lab does not want, a support experience that has changed, or a strategic preference for a fixed-price cloud model.

What a fixed-price cloud LIS offers a small lab

For a physician office lab or small clinical lab that does decide to evaluate alternatives, the practical difference in 2026 is less about features and more about commercial model and implementation effort. LIMS IQ Lite is one option; its terms are published on limsiq.com/pricing:

  • Fixed $999 per month, unlimited users, no setup fees, cancel anytime. Headcount never changes the price.
  • Complete POL workflow — patient management with duplicate detection, guided requisition entry with ICD-10 and insurance capture, inbound HL7 orders, accessioning queues and barcode labels, instrument import through supported ASTM, HL7 and file-based patterns, QC limits with pass/warn/fail visibility, reference-range and critical flagging, delta checks, one-step approval, and PDF report delivery by email, fax, print, HL7 or SFTP with a per-requisition delivery log.
  • Live in days from a standardized intake checklist, with a starter chemistry and hematology menu included.
  • Compliance support — role-based access, an audit trail across the specimen lifecycle, and encryption in transit and at rest, supporting CLIA, CAP and HIPAA capability areas.
  • A growth path — Lite is a standardized configuration of the full LIMS IQ platform, so a lab that later needs integrated billing, custom report templates, multi-site profiles or custom interfaces moves up without changing vendor.

What Lite deliberately does not include: integrated claims billing, custom report design, multi-stage approval chains, preliminary reports and multi-site tenancy. Patient and client portals are separate subscriptions; the Patient Portal is $499 per month and works with almost any LIS, including Harvest. Labs that need those capabilities should evaluate full LIMS IQ, which is priced on monthly requisition volume, or the other vendors below.

Other alternatives worth naming

A fair shortlist for a small lab leaving any incumbent, on public positioning as of September 2026:

  • CGM LabDAQ (CompuGroup Medical) — installed in physician offices, clinics, independent labs and hospitals; “hosted onsite or in the cloud by CompuGroup Medical”; a POL configuration “designed for the lower volume, physician office laboratory”; pricing on request. [5][6] See CGM LabDAQ alternatives for detail.
  • Dendi LIS — cloud-native, “simple, fixed, monthly subscription based on the quantity and types of integrations,” unlimited users, a $2,200 per month starter tier for new labs, and published implementation timelines of two to six weeks; positioned for precision diagnostics, toxicology, molecular and POL labs. [7][8] See Dendi LIS vs LIMS IQ.
  • LigoLab — an integrated LIS and RCM platform, cloud or on-premises, per-transaction volume pricing with an Essential tier for “small pathology, molecular, and reference laboratories”; pricing figures not published. [9][10]

The best cloud LIS for small labs comparison scores all of these on ten criteria.

Migration steps from Harvest to a new LIS

Whatever the destination, the sequence is the same. The LIS data migration guide covers each step in depth.

  1. Secure the export first. Before giving notice, obtain the patient master, provider master, test catalog and historical results in discrete, queryable form. Confirm the format and cost under the contract.
  2. Decide the retention split. Migrate what CLIA and state rules require the lab to keep accessible and what clinicians use for delta checks and trending; archive the rest read-only.
  3. Inventory interfaces. List every analyzer and the EMR connection with direction (orders, results, both) and message type. This list drives both the timeline and the quote.
  4. Rebuild the test catalog deliberately. Use the move to retire unused tests, fix reference ranges and align LOINC codes rather than copying the old compendium verbatim.
  5. Validate. Run parallel on a defined sample set, compare results and reports, and document IQ/OQ/PQ evidence as described in the LIS validation guide.
  6. Train on the real workflow, then cut over on a date. Short parallel runs with a hard cutover beat long dual-entry periods.

On LIMS IQ Lite the configuration side of this is checklist-driven and measured in days; the historical data and interface work is what sets the calendar. The LIS implementation timeline explains what determines each phase.

Request a demo to see LIMS IQ Lite run one of your requisitions end to end, or to discuss a migration plan.

Sources

All competitor facts were checked on September 2, 2026.

  1. Clinisys, “Clinisys acquires Orchard Software,” press release, July 29, 2025 — https://www.clinisys.com/us/en/news/clinisys-acquires-orchard-software/ (also distributed via Business Wire: https://www.businesswire.com/news/home/20250729745245/en/Clinisys-Acquires-Orchard-Software)
  2. Clinisys, “Orchard” history and ONC certification page — https://www.clinisys.com/us/en/history/orchard/
  3. Clinisys, “Clinisys Harvest” product page — https://www.clinisys.com/us/en/products/clinisys-orchard-harvest
  4. Clinisys, “Clinisys Orchard — Enterprise LIS for High-Volume Labs” — https://www.clinisys.com/at/en/products/clinisys-orchard-enterprise/
  5. CompuGroup Medical, “CGM LABDAQ Laboratory Information System” — https://www.cgm.com/usa_en/solutions/physician-office-labs/lab-management-software/cgm-labdaq.html
  6. CompuGroup Medical, “CGM LABDAQ Reports, Specialized Systems, Industry Partners” (CGM LABDAQ POL) — https://www.cgm.com/usa_en/solutions/physician-office-labs/lab-management-software/cgm-labdaq/cgm-labdaq-reporting-systems-partners.html
  7. Dendi, “Modern Clinical Lab LIS Software” — https://dendisoftware.com/dendi-laboratory-information-system
  8. Dendi, home page — https://dendisoftware.com/
  9. LigoLab, home page — https://www.ligolab.com/
  10. LigoLab, “LigoLab’s New Tiered Pricing Model…,” July 1, 2026 — https://www.ligolab.com/post/ligolabs-new-tiered-structure-for-its-lis-platform-delivers-a-tailored-fit-and-maximum-value

Frequently asked

Did Clinisys acquire Orchard Software?
Yes. Clinisys, a Roper Technologies company, announced on July 29, 2025 that it had acquired Orchard Software from the investment firm Francisco Partners, which had owned Orchard since 2019. Clinisys states that Orchard products are now branded with the Clinisys name and will continue to be available and supported. Financial terms were not disclosed.
Is Orchard Harvest being discontinued?
Clinisys has not announced a discontinuation. Its Orchard history page states that Orchard solutions, now branded Clinisys, will continue to be available and supported, and Harvest 14 and 15 received ONC health IT certification in May 2026. The Harvest product page also invites customers to contact Clinisys about converting to Clinisys Orchard, so labs should ask about the roadmap directly.
What should a lab check with its LIS vendor after an acquisition?
After an acquisition a lab should ask for the product roadmap in writing, confirm which support team and hours now apply, review the contract for assignment, renewal and price-change clauses, ask whether any product conversion is expected and who pays for it, and confirm data export rights and formats in case the lab later decides to move.
When does it make sense to stay on Clinisys Harvest?
Staying makes sense when the lab’s analyzers and EHR are already interfaced and stable, the renewal terms are acceptable, the lab needs capabilities Harvest already provides such as point-of-care integration or a veterinary workflow, and Clinisys has confirmed the support and roadmap commitments in writing. Switching an LIS has real cost and should follow a clear reason.
What does LIMS IQ Lite offer as an Orchard Harvest alternative?
LIMS IQ Lite is a cloud LIS for physician office labs and small clinical labs at a fixed $999 per month with unlimited users, no setup fees and cancellation any time. It covers order entry, accessioning, instrument import, QC, approval and PDF report delivery by email, fax, print, HL7 or SFTP, and goes live in days from a standardized checklist.
How long does migrating from Orchard Harvest to a new LIS take?
The duration depends on how much history the lab migrates and how many interfaces it rebuilds. LIMS IQ Lite onboarding runs from a fixed intake checklist and goes live in days; a full LIMS IQ implementation with custom interfaces and historical data conversion is scoped as a phased project. Plan a parallel-run period and a defined cutover date either way.